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Abstract
Alvarez-Lerma and colleagues observed over an 18-day period that
five critically ill patients admitted to a multidisciplinary 18-bed
intensive care unit contracted Burkholderia cepacia from
unopened containers of moisturizing body milk, calling into
question the use in critical care settings of cosmetic products that
do not guarantee sterilization during the manufacturing process. Is
this the answer to the problem, however, or should the use of
lotions in such settings be re-examined?
It appears that the potentially fatal pathogen Burkholderia
cepacia has taken hold of another reservoir for transmission –
in the form of moisturizing body milk [1]. B. cepacia, a Gram-
negative rod bacterium known for its affinity towards and its
virulence in moist environments, presents a clinical challenge
in the treatment and management of susceptible populations
and in the subsequent identification of causative sources
during nosocomial outbreaks. Capable of person-to-person
transmission and transmission through contact with surfaces
such as medical devices and medicines, B. cepacia is an
opportunistic pathogen highly resistant to most antimicrobial
agents and it possesses a 42% mortality rate [2]. The need
for all clinicians to examine more closely their environments in
an effort to halt the spread of B. cepacia is therefore critical.
Alvarez-Lerma and colleagues observed over an 18-day
period that five critically ill patients admitted to a multi-
disciplinary 18-bed intensive care unit contracted the noso-
comial infection B. cepacia [1]. Microbiologic analysis was
performed on the collected oropharyngeal mucosa, urine, and
bronchial aspirates from all patients in the intensive care unit
and on samples of antiseptics, eau de Cologne, and
moisturizing body milk used in routine nursing care. It was
determined that the strains of B. cepacia isolated from the
patients and from the moisturizing body milk were of the
same clone, indicating the lotion was the source of the out-
break. Upon this discovery, the hospital immediately withdrew
the product from routine nursing care hospital wide and
notified the manufacturing company about the B. cepacia
contamination.
Alvarez-Lerma and colleagues strongly recommend cosmetic
products that do not guarantee sterilization during the
manufacturing process should not be used in critical care
settings [1]. From an all or nothing perspective and within the
context that B. cepacia only survived in moisturizing body
milk, this approach would appear practical and the right thing
to do in an effort to promote quality and safe patient care.
Removing nonsterile cosmetic products such as lotion from
the critical care setting, however, would not completely
eradicate or protect patients from B. cepacia infecting
humans in the hospital setting. The fact remains that
B. cepacia has the potential to find its way into reservoirs that
have undergone sterile manufacture because of its affinity for
moist environments. Several recent studies illustrate that
strains of the B. cepacia complex were found in antiseptics,
ultrasound gel, enteral feedings, and albuterol and nasal
sprays – products manufactured in sterile environments [3-6].
In an effort to first do no harm, the clinician must carefully
weigh the risks and benefits of all interventions for every
patient. The critically ill patient in a state of imbalance is more
susceptible and vulnerable to pathogens in their environment;
therefore, a greater need for enhanced analysis of the benefits
and risks inherently exists. It is feasible to ban the use of
lotions in critically ill patients if it is known that B. cepacia
clinically demonstrates higher colonization rates within
moisturizing body milks than any other products, sterilized or
nonsterilized, used in the hospital. Without such evidence that
lotions possess a higher colonization rate for B. cepacia, from
a nursing perspective the potential benefits of the use of
nonsterilized lotion for the patient might be overlooked.
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Nursing practice utilizes lotion in a variety of situations and
patient populations. Lotion, commonly applied to patients
with dry, itchy skin, helps to decrease scratching, which can
lead to skin excoriation and can leave the body open to
infection [7]. Lotion may also be utilized in patients who are
bed-ridden and who present with red areas on bony
prominences. Here, the lotion helps to create a gentle friction
on the reddened areas of the body, which helps to stimulate
blood flow to the surrounding tissue in an effort to ward off
potential development of pressure ulcers. Additionally, the
use of lotions can assist in the donning of latex-free compres-
sion stockings commonly used in a multitude of medical
conditions such as lymphedema and venous insufficiency.
From a holistic perspective, lotions are used to facilitate
patient massage. The use of aids in the bonding process of
parents of babies in the neonatal intensive care unit by
helping to facilitate infant massages, and helps facilitate
sensory integration therapies in children with autism and
sensory processing disorders.
There is no doubt of the tragic magnitude that would ensue if
a widespread deadly outbreak of B. cepacia was to occur
from the use of moisturizing body lotions, especially if those
greatly affected were infants, children, and adults concur-
rently battling critical or chronic illnesses. Halting the spread
of  B. cepacia infection cannot occur only through the
discontinuation of nonsterilized cosmetic products, and
neither can it be guaranteed only with the use of sterilized
products. A tried and true way to take hold of B. cepacia
therefore appears to be through the continued and
regimented practice of adequate hand washing.
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